US – general: Juul Labs has posted its 129-page administrative appeal against the marketing denial order (MDO) issued by the Food and Drug Administration (FDA), explaining the company’s position and describing the MDO as “substantively and procedurally flawed”. Juul has presented data to counter the four main deficiencies listed in the MDO, highlighting the lack of an iterative review, saying a different » Continue Reading. ...
Written by EcigIntelligence || 25th October 2022 || Daily news alerts || FDA | United States